茵栀黄类药品作为治疗黄疸以及急、慢性肝炎患者的良药,一直备受青睐。去年,因其曾致新生儿死亡被国家食药监总局要求其注射剂禁用于新生儿、婴幼儿、孕妇。现今,国家食药监总局又对茵栀黄口服制剂的说明书进行修改,明确了该药制剂会引起 Yin Zhi Huang drugs as jaundice as well as acute and chronic hepatitis medicine, has been favored. Last year, it was banned by the State Food and Drug Administration because of the deaths of newborns for newborns, infants and pregnant women. Today, the State Food and Drug Administration and the instructions of Yin Zhi Huang oral preparations to be amended to make it clear that the medicine will cause